What does the research say about Delta 9 THC, CBD and inflammation?

Cannabis sativa contains more than 400 different chemical compounds. Two of the best known are tetrahydrocannabinol (THC) and CBD.

THC is the cannabinoid that leads to the “high” feeling many people associate with cannabis. CBD does not provide these same effects. Research suggests that CBD can ease inflammation, among other potential benefits.

Research suggests that Delta 9 THC and CBD’s anti-inflammatory properties may be beneficial for rheumatoid arthritis, as it affects certain cell viability. It may also have a synergetic effect on rheumatoid arthritis medication.

A 2020 review suggests that Delta 9 THC and CBD’s properties can provide anti-oxidative effects because of CBD’s specific molecular structure. Therefore, it may have anti-inflammatory benefits for conditions that can result from oxidative stress.

Most studies have not reviewed the long-term effects of Delta 9 THC and CBD, and researchers need to conduct more studies with human participants. However, experts believe that the research results so far may have therapeutic implications.

One 2017 review found that CBD’s anti-inflammatory properties may help with the following conditions: